Sanofi Pasteur unveils DTaP-IPV booster vaccine for preschoolers in India

Published On 2020-10-02 04:00 GMT   |   Update On 2020-10-02 04:00 GMT

New Delhi: Sanofi Pasteur India, vaccine unit of pharma firm Sanofi, on Wednesday said it has launched a booster vaccine for preschoolers to protect against four major diseases - diphtheria, pertussis, tetanus and polio.The four-in-one (DTaP-IPV) vaccine named ''Tetraxim'' by reducing the number of injections, increases comfort and improves vaccination compliance for children and reduces...

Login or Register to read the full article

New Delhi: Sanofi Pasteur India, vaccine unit of pharma firm Sanofi, on Wednesday said it has launched a booster vaccine for preschoolers to protect against four major diseases - diphtheria, pertussis, tetanus and polio.

The four-in-one (DTaP-IPV) vaccine named ''Tetraxim'' by reducing the number of injections, increases comfort and improves vaccination compliance for children and reduces parental anxiety, the company said in a statement.

With Tetraxim, Sanofi Pasteur currently protects school children in more than 100 countries, with 63 million doses distributed worldwide, it added.

"Booster vaccines are designed to boost the immunity acquired during prior vaccination.

"It works as a reminder for a child''s immune system and can also stop the spread of infection to their siblings and grandparents, making it important to maintain vaccination schedules of preschoolers," Sanofi Pasteur India Country Head Annapurna Das said.

Read also: Sanofi concludes acquisition of Principia Biopharma



Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News